NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12 | -68.4% | 16,614 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $38 | -99.9% | 16,614 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $53,000 | -15.9% | 16,614 | -1.1% | 0.00% | -50.0% |
| Q2 2022 | $63,000 | -39.4% | 16,800 | -13.5% | 0.00% | 0.0% |
| Q1 2022 | $104,000 | -59.7% | 19,433 | +1.9% | 0.00% | -66.7% |
| Q4 2021 | $258,000 | -14.0% | 19,063 | +14.0% | 0.01% | -14.3% |
| Q3 2021 | $300,000 | +5.3% | 16,723 | +0.7% | 0.01% | 0.0% |
| Q2 2021 | $285,000 | -7.2% | 16,613 | +8.3% | 0.01% | -12.5% |
| Q1 2021 | $307,000 | +18.5% | 15,333 | +0.7% | 0.01% | +14.3% |
| Q4 2020 | $259,000 | +3.6% | 15,233 | +0.9% | 0.01% | 0.0% |
| Q3 2020 | $250,000 | -28.0% | 15,093 | +0.7% | 0.01% | -30.0% |
| Q2 2020 | $347,000 | +38.8% | 14,983 | +7.2% | 0.01% | +11.1% |
| Q1 2020 | $250,000 | -20.6% | 13,980 | -4.2% | 0.01% | 0.0% |
| Q4 2019 | $315,000 | +29.1% | 14,600 | +9.1% | 0.01% | +28.6% |
| Q3 2019 | $244,000 | -51.9% | 13,380 | -6.1% | 0.01% | -50.0% |
| Q2 2019 | $507,000 | +8.3% | 14,244 | +2.2% | 0.01% | +7.7% |
| Q1 2019 | $468,000 | +4.5% | 13,943 | +2.2% | 0.01% | -7.1% |
| Q4 2018 | $448,000 | -58.5% | 13,643 | -22.9% | 0.01% | -48.1% |
| Q3 2018 | $1,079,000 | +24.7% | 17,701 | -0.1% | 0.03% | +17.4% |
| Q2 2018 | $865,000 | -41.6% | 17,710 | +27.0% | 0.02% | -39.5% |
| Q1 2018 | $1,482,000 | -17.8% | 13,945 | -53.8% | 0.04% | -11.6% |
| Q4 2017 | $1,802,000 | +156.0% | 30,168 | +2.8% | 0.04% | +138.9% |
| Q3 2017 | $704,000 | 0.0% | 29,339 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $704,000 | – | 29,339 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |